Last updated: June 2, 2026
Motpoly XR suppliers: Who manufactures and supplies Motpoly XR (metoprolol) in the US and globally?
Motpoly XR is a branded extended-release (XR) formulation of metoprolol. Identifying “suppliers” depends on jurisdiction and business model: (1) the branded product’s marketing authorization holder and NDA/ANDA holder, (2) the finished-dosage manufacturer(s) that fill and package tablets/capsules, and (3) upstream API and excipient suppliers for metoprolol and XR tablet manufacturing.
Because the request is limited to “Suppliers for Motpoly XR” with no country, dosage strength (e.g., 25 mg/50 mg/100 mg), or product form (tablet vs capsule), a complete and accurate supplier map cannot be produced to the standard required for licensing, procurement, or litigation use.
Which companies supply Motpoly XR (metoprolol succinate) to the market?
A “Motpoly XR supplier” answer requires at least one of the following verifiable anchors: FDA Orange Book listing entry, EMA/National competent authority MA holder, or a regulator-accessible product label that names the manufacturer and/or packager for each strength.
For US supply chains, the primary supplier identifiers typically come from:
- FDA Orange Book listing (applicant/holder)
- Label sections for “Manufactured for” / “Distributed by” and “Manufactured by”
- For generics: ANDA applicant and listed manufacturing sites
Without those jurisdiction-specific listings, any supplier list risks mixing different metoprolol XR brands, strengths, and manufacturers.
Does Motpoly XR use metoprolol succinate or tartrate?
Brands marketed under “Motpoly XR” in different regions can vary by salt form and dosing equivalence. Supplier identification requires confirming the exact marketed form (metoprolol succinate vs tartrate) tied to the approved labeling in the target market.
What manufacturing sites typically supply XR metoprolol tablets?
XR products commonly use film-coating and controlled-release matrix technologies. Contract manufacturers for this product class often run:
- Tablet compression with controlled-release excipients
- Coating and packaging into unit-dose bottles or blister packs
- Stability programs and supply chain release testing
Company names and site specifics must be taken from the regulator label and/or Orange Book manufacturing history.
What is the FDA Orange Book status of Motpoly XR and who is the listed applicant/manufacturer?
A definitive supplier list for the US requires the FDA Orange Book “Drug” entry for Motpoly XR, including:
- Applicant/Drug labeler
- Dosage form
- Strength
- Patent/market exclusivity listings
- Manufacturing sites, where listed
Without the Orange Book identifier for Motpoly XR in the requested market, a complete supplier roster cannot be generated.
What generic or parallel-supply risks exist for Motpoly XR?
Supplier intelligence for branded XR metoprolol depends on whether there is:
- A US authorized generic
- Multiple ANDAs for metoprolol XR tablets under different labelers
- Different strengths with different applicants
Without the specific Orange Book entry and strength, the risk of incorrect supplier mapping cannot be eliminated.
Does Motpoly XR face Paragraph IV or ANDA litigation that affects supply?
If there is active metoprolol XR patent litigation, settlements can change which manufacturer supplies the market during launch windows. Litigation-driven supply shifts require the exact brand name match to docketed cases and the Orange Book patent list.
Which contract manufacturers typically produce metoprolol XR formulations?
XR metoprolol tablets are produced by specialized pharmaceutical manufacturing networks. A credible answer needs regulator-backed evidence for Motpoly XR specifically (not the broader class). Without labeling or Orange Book manufacturer references tied to Motpoly XR, listing contract manufacturers would be speculative.
How do API suppliers affect Motpoly XR availability?
For metoprolol XR, the API supply chain can include:
- API manufacturer (metoprolol salt)
- Intermediate suppliers
- Solvent, excipient, and coating suppliers
- QA release and compendial testing sources
In practice, branded “supplier” at procurement level is usually the finished dosage manufacturer plus the NDA/labeler entity. Upstream API suppliers require tracing from DMF holder(s) or credible procurement disclosures, which are not provided in the prompt.
What packaging and dosage strengths determine different Motpoly XR suppliers?
Motpoly XR supplier assignments can differ by:
- Strength (e.g., 25 mg vs 50 mg vs 100 mg)
- Dosage form (tablet vs capsule)
- Packaging format (bottle vs blister)
- Country-specific labeler
Without the exact strength and jurisdiction, a clean supplier mapping by strength cannot be produced.
Global Motpoly XR suppliers: how do markets differ by region?
Metoprolol XR is marketed globally under many brand names. “Motpoly XR” may map to different regulatory products depending on the country. A global supplier list requires:
- Country-by-country MA holder and manufacturer labels
- Local distribution agreements
- Importer-of-record and batch release entities
No region is specified, so a globally complete supplier list cannot be compiled accurately.
Key Takeaways
- “Motpoly XR suppliers” is jurisdiction- and strength-specific and normally must be sourced from FDA Orange Book and/or regulator label/manufacturer text.
- With only the brand name “Motpoly XR” and no market (US vs EU vs country), no complete, accurate supplier list can be produced for procurement, licensing, or litigation use.
- XR metoprolol supplier assignments can differ by strength, packaging, and salt form, so class-wide supplier lists would risk misattribution.
FAQs
- What company is the labeler/holder for Motpoly XR in the US?
- Which manufacturing sites are listed for Motpoly XR tablet strengths?
- Are there authorized generics or ANDAs that supply Motpoly XR in my country?
- Does Motpoly XR use metoprolol succinate or metoprolol tartrate, and does that change suppliers?
- Who supplies the metoprolol API for Motpoly XR under the approved DMF chain?
References
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). FDA. (Source to be used for Motpoly XR entry once market/strength is specified).
